These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 2468058

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. In vivo evidence of positive inotropism of EMD 57033 through calcium sensitization.
    Haeusler G, Jonas R, Minck KO, Schliep HJ, Schelling P, Weygandt H, Lues I.
    J Cardiovasc Pharmacol; 1997 May; 29(5):647-55. PubMed ID: 9213208
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Cardiotonic activity of milrinone, a new and potent cardiac bipyridine, on the normal and failing heart of experimental animals.
    Alousi AA, Canter JM, Montenaro MJ, Fort DJ, Ferrari RA.
    J Cardiovasc Pharmacol; 1983 May; 5(5):792-803. PubMed ID: 6195467
    [Abstract] [Full Text] [Related]

  • 25. Efficacy and safety of the novel Na+,K(+)-ATPase inhibitor 20R 14 beta-amino 3 beta-rhamnosyl 5 beta-pregnan 20 beta-ol in a dog model of heart failure.
    Maixent JM, Berrebi Bertrand I, Lelièvre LG, Fénard S.
    Arzneimittelforschung; 1992 Nov; 42(11):1301-5. PubMed ID: 1337248
    [Abstract] [Full Text] [Related]

  • 26. Studies aimed at elucidating the mechanism of action of CI-914, a new cardiotonic agent.
    Weishaar RE, Quade M, Schenden JA, Boyd DK, Evans DB.
    Eur J Pharmacol; 1985 Dec 17; 119(3):205-15. PubMed ID: 3004993
    [Abstract] [Full Text] [Related]

  • 27. [Effect of Chinese-made vesnarinone on experimental heart failure of dog].
    Du J, Yang Z.
    Hua Xi Yi Ke Da Xue Xue Bao; 1992 Jun 17; 23(2):178-80. PubMed ID: 1452153
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Inhibition of cardiac phosphodiesterase III by the novel cardiotonic agent 6-[4-(4'-pyridyl)aminophenyl]-4,5-dihydro-3(2H)-pyridazinone hydrochloride.
    Sellin LC, Alajoutsijärvi A, Törnquist K, Fraser M, Pippuri A, Ojala I.
    Arzneimittelforschung; 1988 Dec 17; 38(12):1787-9. PubMed ID: 2854467
    [Abstract] [Full Text] [Related]

  • 31. 4-Aroyl-1,3-dihydro-2H-imidazol-2-ones, a new class of cardiotonic agents.
    Schnettler RA, Dage RC, Grisar JM.
    J Med Chem; 1982 Dec 17; 25(12):1477-81. PubMed ID: 7154009
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Cardiovascular profile of Ro 13-6438, a novel positive inotropic agent with vasodilating properties.
    Eigenmann R, Gerold M, Holck M.
    J Cardiovasc Pharmacol; 1984 Dec 17; 6(3):511-9. PubMed ID: 6202980
    [Abstract] [Full Text] [Related]

  • 34. Pharmacology of LY175326: a potent cardiotonic agent with vasodilator activities.
    Hayes JS, Pollock GD, Wilson H, Bowling N, Robertson DW.
    J Pharmacol Exp Ther; 1985 May 17; 233(2):318-26. PubMed ID: 3999023
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Phosphodiesterase inhibition by new cardiotonic agents: mechanism of action and possible clinical relevance in the therapy of congestive heart failure.
    von der Leyen H.
    Klin Wochenschr; 1989 Jun 15; 67(12):605-15. PubMed ID: 2671473
    [Abstract] [Full Text] [Related]

  • 38. Positive chronotropic and inotropic effects of pimobendan (UD-CG 115 BS) in isolated, cross-circulated canine heart preparations.
    Furukawa Y, Akahane K, Ogiwara Y, Haniuda M, Chiba S.
    Arch Int Pharmacodyn Ther; 1989 Jun 15; 300():159-73. PubMed ID: 2575887
    [Abstract] [Full Text] [Related]

  • 39. Improvement of cardiac performance by AR-L 115 BS, a new cardiotonic drug, in the experimental failing dog heart.
    Morita T, Satoh K, Taira N.
    Jpn Heart J; 1984 May 15; 25(3):439-45. PubMed ID: 6088828
    [Abstract] [Full Text] [Related]

  • 40. Cardiac effects of the novel pyridazinone derivative 6-[4-[2-[3-(5-chloro-2-cyanophenoxy)-2-hydroxypropylamino]- 2- methylpropylamino]phenyl]-4,5-dihydro-5-methyl-3(2H) pyridazinone monoethyl maleate and its metabolite in isolated heart preparations of guinea pigs and dogs.
    Ishimori T, Gotanda K, Sasaki T, Shinbo A, Asano H, Miyazawa K, Miyasaka K.
    Arzneimittelforschung; 1994 May 15; 44(5):583-8. PubMed ID: 7912931
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.